DWOCX
Price
$15.68
Change
+$0.18 (+1.16%)
Updated
Aug 6 closing price
Net Assets
1.67B
RGEBX
Price
$80.26
Change
+$0.70 (+0.88%)
Updated
Aug 6 closing price
Net Assets
322.41B
Interact to see
Advertisement

DWOCX vs RGEBX

Header iconDWOCX vs RGEBX Comparison
Open Charts DWOCX vs RGEBXBanner chart's image
BNY Mellon Research Growth C
Price$15.68
Change+$0.18 (+1.16%)
VolumeN/A
Net Assets1.67B
American Funds Growth Fund of Amer R2E
Price$80.26
Change+$0.70 (+0.88%)
VolumeN/A
Net Assets322.41B
DWOCX vs RGEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
DWOCX vs. RGEBX commentary
Aug 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DWOCX is a Buy and RGEBX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGEBX has more cash in the bank: 322B vs. DWOCX (1.67B). DWOCX (0.00) and RGEBX (0.00) have matching dividends . DWOCX was incepted earlier than RGEBX: DWOCX (17 years) vs RGEBX (11 years). DWOCX (1.93) is less costly to investors than RGEBX (1.09). DWOCX is a more actively managed with annual turnover of: 27.94 vs. RGEBX (25.00). RGEBX has a lower initial minimum investment than DWOCX: RGEBX (250) vs DWOCX (1000). RGEBX annual gain was more profitable for investors over the last year : 19.90 vs. DWOCX (12.48). RGEBX return over 5 years is better than : 39.18 vs. DWOCX (-5.95).
DWOCXRGEBXDWOCX / RGEBX
Total Expense Ratio1.751.09161%
Annual Report Gross Expense Ratio1.931.09177%
Fund Existence17 years11 years-
Gain YTD-0.32212.346-3%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.67B322B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year12.4819.9063%
Returns for 3 years34.5543.6879%
Returns for 5 years-5.9539.18-15%
Returns for 10 years12.0878.7115%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLPPY5.100.02
+0.32%
Hang Lung Properties Ltd.
IVSBF29.25N/A
N/A
Investors AB
RKVTD0.35N/A
N/A
RAKOVINA THERAPEUTICS INC
PEYUF13.82-0.11
-0.76%
Peyto Exploration & Development Corp
XAUMF6.22-0.15
-2.29%
Goldmoney Inc.